Publication | Closed Access

Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

AsthmaAllergyPlacebo-controlled Phase 3Clinical TherapeuticPharmacologyClinical TrialsPulmonary PharmacologyPulmonary MedicinePharmacotherapyHigh-dosage Inhaled CorticosteroidsPharmacologic InterventionMedicineSevere Asthma